Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma

References

• Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: Impact on clinical outcome. Nat Rev Cancer 2012; 12:298-306; PMID: 22419253; http://dx.doi.org/10.1038/nrc3245
   PubMed Web of Science ®Google Scholar
• Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID: 17008531; http://dx.doi.org/313/5795/1960
   PubMed Web of Science ®Google Scholar
• Galon J, Fridman WH, Pages F. The adaptive immunologic microenvironment in colorectal cancer: A novel perspective. Cancer Res 2007; 67:1883-6; PMID: 17332313; http://dx.doi.org/67/5/1883
   PubMed Web of Science ®Google Scholar
• Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353:2654-66; PMID: 16371631; http://dx.doi.org/353/25/2654
   PubMed Web of Science ®Google Scholar
• Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, Banham AH. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 2006; 24:5373-80; PMID: 17135638; http://dx.doi.org/24/34/5373
   PubMed Web of Science ®Google Scholar
• Gobert M, Treilleux I, Bendriss-Vermare N, Bachelot T, Goddard-Leon S, Arfi V, Biota C, Doffin AC, Durand I, Olive D et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 2009; 69:2000-9; PMID: 19244125; http://dx.doi.org/10.1158/0008-5472.CAN-08-2360
   PubMed Web of Science ®Google Scholar
• Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007; 25:2586-93; PMID: 17577038; http://dx.doi.org/25/18/2586
   PubMed Web of Science ®Google Scholar
• Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007; 132:2328-39; PMID: 17570208; http://dx.doi.org/S0016-5085(07)00628-2
   PubMed Web of Science ®Google Scholar
• Iwamoto T, Bianchini G, Booser D, Qi Y, Coutant C, Shiang CY, Santarpia L, Matsuoka J, Hortobagyi GN, Symmans WF et al. Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer. J Natl Cancer Inst 2011; 103:264-72; PMID: 21191116; http://dx.doi.org/10.1093/jnci/djq524
   PubMed Web of Science ®Google Scholar
• Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med 2009; 360:790-800; PMID: 19228622; http://dx.doi.org/10.1056/NEJMra0801289
   PubMed Web of Science ®Google Scholar
• Halama N, Michel S, Kloor M, Zoernig I, Benner A, Spille A, Pommerencke T, von Knebel DM, Folprecht G, Luber B et al. Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy. Cancer Res 2011; 71:5670-7; PMID: 21846824; http://dx.doi.org/10.1158/0008-5472.CAN-11-0268
   PubMed Web of Science ®Google Scholar
• Cheung NK, Dyer MA. Neuroblastoma: Developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 2013; 13:397-411; PMID: 23702928; http://dx.doi.org/10.1038/nrc3526
   PubMed Web of Science ®Google Scholar
• Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010; 362:2202-11; PMID: 20558371; http://dx.doi.org/10.1056/NEJMra0804577
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Hanada R, Kikuchi A, Ichikawa M, Aihara T, Oguma E, Moritani T, Shimanuki Y, Tanimura M, Hayashi Y. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 1998; 16:1265-9; PMID: 9552024
   PubMed Web of Science ®Google Scholar
• Bolande RP. A natural immune system in pregnancy serum lethal to human neuroblastoma cells: A possible mechanism of spontaneous regression. Perspect Pediatr Pathol 1992; 16:120-33; PMID: 1470503
   PubMedGoogle Scholar
• Martin RF, Beckwith JB. Lymphoid infiltrates in neuroblastomas: Their occurrence and prognostic significance. J Pediatr Surg 1968; 3:161-4; PMID: 5655566; http://dx.doi.org/10.1016/0022-3468(68)91005-1
   PubMedGoogle Scholar
• Lauder I, Aherne W. The significance of lymphocytic infiltration in neuroblastoma. Br J Cancer 1972; 26:321-30; PMID: 5071193; http://dx.doi.org/10.1038/bjc.1972.43
   PubMed Web of Science ®Google Scholar
• Facchetti P, Prigione I, Ghiotto F, Tasso P, Garaventa A, Pistoia V. Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: Neuroblastoma. Cancer Immunol Immunother 1996; 42:170-8; PMID: 8640845; http://dx.doi.org/10.1007/s002620050267
   PubMed Web of Science ®Google Scholar
• Carlson LM, De Geer A, Sveinbjornsson B, Orrego A, Martinsson T, Kogner P, Levitskaya J. The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes. Oncoimmunology 2013; 2: e23618; PMID: 23802089; http://dx.doi.org/10.4161/onci.23618
   PubMedGoogle Scholar
• Maris JM. The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr 2005; 17:7-13; PMID: 15659956; http://dx.doi.org/00008480-200502000-00004
   PubMed Web of Science ®Google Scholar
• Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11:1466-77; PMID: 8336186
   PubMed Web of Science ®Google Scholar
• Cho Y, Miyamoto M, Kato K, Fukunaga A, Shichinohe T, Kawarada Y, Hida Y, Oshikiri T, Kurokawa T, Suzuoki M et al. CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res 2003; 63:1555-9; PMID: 12670904
   PubMed Web of Science ®Google Scholar
• Zajac AJ, Murali-Krishna K, Blattman JN, Ahmed R. Therapeutic vaccination against chronic viral infection: The importance of cooperation between CD4+ and CD8+ T cells. Curr Opin Immunol 1998; 10:444-9; PMID: 9722921; http://dx.doi.org/S0952-7915(98)80119-2
   PubMed Web of Science ®Google Scholar
• Whitmire JK, Ahmed R. Costimulation in antiviral immunity: Differential requirements for CD4(+) and CD8(+) T cell responses. Curr Opin Immunol 2000; 12:448-55; PMID: 10899032; http://dx.doi.org/S0952-7915(00)00119-9
   PubMed Web of Science ®Google Scholar
• Bevan MJ. Helping the CD8(+) T-cell response. Nat Rev Immunol 2004; 4:595-602; PMID: 15286726; http://dx.doi.org/10.1038/nri1413
   PubMed Web of Science ®Google Scholar
• Zhang N, Bevan MJ. CD8(+) T cells: Foot soldiers of the immune system. Immunity 2011; 35:161-8; PMID: 21867926; http://dx.doi.org/10.1016/j.immuni.2011.07.010
   PubMed Web of Science ®Google Scholar
• Matloubian M, Concepcion RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 1994; 68:8056-63; PMID: 7966595
   PubMed Web of Science ®Google Scholar
• Marzo AL, Lake RA, Robinson BW, Scott B. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors. Cancer Res 1999; 59:1071-9; PMID: 10070965
   PubMed Web of Science ®Google Scholar
• Preston CC, Maurer MJ, Oberg AL, Visscher DW, Kalli KR, Hartmann LC, Goode EL, Knutson KL. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer. PLoS One 2013; 8: e80063; PMID: 24244610; http://dx.doi.org/10.1371/journal.pone.0080063
   PubMed Web of Science ®Google Scholar
• Hiraoka K, Miyamoto M, Cho Y, Suzuoki M, Oshikiri T, Nakakubo Y, Itoh T, Ohbuchi T, Kondo S, Katoh H. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer 2006; 94:275-80; PMID: 16421594; http://dx.doi.org/6602934
   PubMed Web of Science ®Google Scholar
• Khan H, Pillarisetty VG, Katz SC. The prognostic value of liver tumor T cell infiltrates. J Surg Res 2014; 191:189-95; PMID: 25033707; http://dx.doi.org/10.1016/j.jss.2014.06.001
   PubMed Web of Science ®Google Scholar
• Filosi M, Visintainer R, Riccadonna S, Jurman G, Furlanello C. Stability indicators in network reconstruction. PLoS One 2014; 9: e89815; PMID: 24587057; http://dx.doi.org/10.1371/journal.pone.0089815
   PubMedGoogle Scholar
• Squire R, Fowler CL, Brooks SP, Rich GA, Cooney DR. The relationship of class I MHC antigen expression to stage IV-S disease and survival in neuroblastoma. J Pediatr Surg 1990; 25:381-6; PMID: 2329454; http://dx.doi.org/0022-3468(90)90375-J
   PubMed Web of Science ®Google Scholar
• Kataoka Y, Matsumura T, Yamamoto S, Sugimoto T, Sawada T. Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma. Cancer Lett 1993; 73:11-21; PMID: 8402593; http://dx.doi.org/0304-3835(93)90182-9
   PubMed Web of Science ®Google Scholar
• Valteau D, Scott V, Carcelain G, Hartmann O, Escudier B, Hercend T, Triebel F. T-cell receptor repertoire in neuroblastoma patients. Cancer Res 1996; 56:362-9; PMID: 8542593
   PubMed Web of Science ®Google Scholar
• Pena SV, Hanson DA, Carr BA, Goralski TJ, Krensky AM. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol 1997; 158:2680-8; PMID: 9058801
   PubMed Web of Science ®Google Scholar
• Nagasawa M, Kawamoto H, Tsuji Y, Mizutani S. Transient increase of serum granulysin in a stage IVs neuroblastoma patient during spontaneous regression: Case report. Int J Hematol 2005; 82:456-7; PMID: 16533752; http://dx.doi.org/51FW2MBQXVEEWYCT
   PubMed Web of Science ®Google Scholar
• Lorenzi S, Forloni M, Cifaldi L, Antonucci C, Citti A, Boldrini R, Pezzullo M, Castellano A, Russo V, van der Bruggen P et al. IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma. PLoS One 2012; 7: e46928; PMID: 23071666; http://dx.doi.org/10.1371/journal.pone.0046928
   PubMedGoogle Scholar
• Forloni M, Albini S, Limongi MZ, Cifaldi L, Boldrini R, Nicotra MR, Giannini G, Natali PG, Giacomini P, Fruci D. NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells. Cancer Res 2010; 70:916-24; PMID: 20103633; http://dx.doi.org/10.1158/0008-5472.CAN-09-2582
   PubMed Web of Science ®Google Scholar
• Raffaghello L, Prigione I, Bocca P, Morandi F, Camoriano M, Gambini C, Wang X, Ferrone S, Pistoia V. Multiple defects of the antigen-processing machinery components in human neuroblastoma: Immunotherapeutic implications. Oncogene 2005; 24:4634-44; PMID: 15897905; http://dx.doi.org/1208594
   PubMed Web of Science ®Google Scholar
• Coughlin CM, Fleming MD, Carroll RG, Pawel BR, Hogarty MD, Shan X, Vance BA, Cohen JN, Jairaj S, Lord EM et al. Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma. J Clin Oncol 2006; 24:5725-34; PMID: 17179106; http://dx.doi.org/24/36/5725
   PubMed Web of Science ®Google Scholar
• Reid GS, Shan X, Coughlin CM, Lassoued W, Pawel BR, Wexler LH, Thiele CJ, Tsokos M, Pinkus JL, Pinkus GS et al. Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivo. Clin Cancer Res 2009; 15:6602-8; PMID: 19825945; http://dx.doi.org/10.1158/1078-0432.CCR-09-0829
   PubMed Web of Science ®Google Scholar
• Zhou F. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int Rev Immunol 2009; 28:239-60; PMID: 19811323; http://dx.doi.org/10.1080/08830180902978120
   PubMed Web of Science ®Google Scholar
• Lesinski GB, Zimmerer JM, Kreiner M, Trefry J, Bill MA, Young GS, Becknell B, Carson WE, 3rd. Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells. BMC Cancer 2010; 10:142, 2407-10-142; PMID: 20398276; http://dx.doi.org/10.1186/1471-2407-10-142
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Grunwald V, Thompson JA, Figlin RA, Hollaender N et al. Phase 3 trial of everolimus for metastatic renal cell carcinoma : Final results and analysis of prognostic factors. Cancer 2010; 116:4256-65; PMID: 20549832; http://dx.doi.org/10.1002/cncr.25219
   PubMed Web of Science ®Google Scholar
• Hinrichs CS, Rosenberg SA. Exploiting the curative potential of adoptive T-cell therapy for cancer. Immunol Rev 2014; 257:56-71; PMID: 24329789; http://dx.doi.org/10.1111/imr.12132
   PubMed Web of Science ®Google Scholar
• Emerson RO, Sherwood AM, Rieder MJ, Guenthoer J, Williamson DW, Carlson CS, Drescher CW, Tewari M, Bielas JH, Robins HS. High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer. J Pathol 2013; 231:433-40; PMID: 24027095; http://dx.doi.org/10.1002/path.4260
   PubMed Web of Science ®Google Scholar
• Gerlinger M, Quezada SA, Peggs KS, Furness AJ, Fisher R, Marafioti T, Shende VH, McGranahan N, Rowan AJ, Hazell S et al. Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas. J Pathol 2013; 231:424-32; PMID: 24122851; http://dx.doi.org/10.1002/path.4284
   PubMed Web of Science ®Google Scholar
• Reissfelder C, Stamova S, Gossmann C, Braun M, Bonertz A, Walliczek U, Grimm M, Rahbari NN, Koch M, Saadati M et al. Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis. J Clin Invest 2015; 125:739-51; PMID: 25562322; http://dx.doi.org/10.1172/JCI74894
   PubMed Web of Science ®Google Scholar
• Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK et al. The international neuroblastoma pathology classification (the shimada system). Cancer 1999; 86:364-72; PMID: 10421273; http://dx.doi.org/10.1002/(SICI)1097-0142(19990715)86:23.0.CO;2-7
   PubMed Web of Science ®Google Scholar
• Mathew P, Valentine MB, Bowman LC, Rowe ST, Nash MB, Valentine VA, Cohn SL, Castleberry RP, Brodeur GM, Look AT. Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: A pediatric oncology group study. Neoplasia 2001; 3:105-9; PMID: 11420745; http://dx.doi.org/10.1038/sj/neo/7900146
   PubMed Web of Science ®Google Scholar
• Stam NJ, Spits H, Ploegh HL. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 1986; 137:2299-306; PMID: 3760563
   PubMed Web of Science ®Google Scholar
• Yuan Y, Failmezger H, Rueda OM, Ali HR, Graf S, Chin SF, Schwarz RF, Curtis C, Dunning MJ, Bardwell H et al. Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling. Sci Transl Med 2012; 4:157ra143; PMID: 23100629; http://dx.doi.org/10.1126/scitranslmed.3004330
   PubMed Web of Science ®Google Scholar
• Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 2001; 23:291-9; PMID: 11531144
   PubMed Web of Science ®Google Scholar
• Keane C, Gill D, Vari F, Cross D, Griffiths L, Gandhi M. CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy. Am J Hematol 2013; 88:273-6; PMID: 23460351; http://dx.doi.org/10.1002/ajh.23398
   PubMed Web of Science ®Google Scholar
• Seo J, Park JS, Nam JH, Bang D, Sohn S, Lee ES, Park KS. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with behcet's disease. Tissue Antigens 2007; 70:307-13; PMID: 17767552; http://dx.doi.org/TAN907
   PubMed Web of Science ®Google Scholar
• Benaglia T, Chauveau D, Hunter DR, Young D. Mixtools: An R package for analyzing finite mixture models. J Statist Soft 2009; 32:1-29
   Web of Science ®Google Scholar
• Matthews BW. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta 1975; 405:442-51; PMID: 1180967; http://dx.doi.org/10.1016/0005-2795(75)90109-9
   PubMed Web of Science ®Google Scholar